Who We Serve
FDA RA Group works with organizations across the medical device and diagnostic ecosystem, providing practical regulatory and quality support aligned with each client’s products, responsibilities, stage of development, and business objectives.
Startups and First-Time Device and IVD Companies
First-time device and IVD companies face a steep learning curve. We help startups build the regulatory and quality foundation they need, right-sized for their stage, without the overhead of premature complexity.
- Regulatory pathway selection and FDA strategy
- First-time QMS design and implementation
- Design control and DHF development
- Pre-Submission and clinical strategy
IVD Ecosystem
In Vitro Diagnostic Companies
IVD products have unique regulatory pathways and technical documentation requirements. We bring specific expertise in IVD classification, performance evaluation, clinical evidence expectations, and the evolving FDA framework for diagnostics.
Medical Device Manufacturers
From simple Class I devices to complex Class III systems, we support medical device manufacturers across the product lifecycle, from design control through postmarket surveillance. Our consultants understand the technical, regulatory, and operational challenges specific to device companies.
Design and Development
Regulatory Submission
Manufacturing
Commercialization
Postmarket Compliance
Developing Processes
Early operating structure
Structured QMS
Documented quality systems
Supplier Oversight
Managed supply chain
Inspection Readiness
Prepared for scrutiny
Sustained Compliance
Scalable and mature
Growth-Stage Manufacturers
As companies scale, their quality systems must scale with them. We help growth-stage manufacturers mature their processes, prepare for increased regulatory scrutiny, and build the infrastructure needed for sustained compliance.
- QMS maturity assessment and improvement
- Supplier management program development
- International market expansion support
- Preparation for first FDA inspection
Manufacturers Facing Compliance Challenges
Even experienced manufacturers face compliance challenges, whether from regulatory changes, Form FDA 483 observations, organizational transitions, or acquisitions. We provide the senior-level support needed to address complex compliance situations efficiently.
- Post-inspection remediation and Form FDA 483 response
- Warning Letter resolution
- QMS overhaul and system modernization
- MDSAP and multi-market compliance alignment
Investors and Private Equity Firms
Investors and private equity firms need to understand regulatory and quality risk before and after acquisition. We provide QA and RA due diligence assessments and post-acquisition compliance support for portfolio companies.
- Pre-acquisition regulatory and quality due diligence
- Portfolio company compliance assessment
- Post-acquisition quality system integration
- Regulatory risk evaluation and reporting
FDA pathway, submissions, and approval status
QMS maturity, documentation, and audit history
Inspection risk, observations, and open issues
Post-acquisition quality planning and harmonization
Additional Organizations We Support
FDA RA Group works with clients globally while maintaining a primary focus on United States FDA regulatory and quality requirements.
Clinical Laboratories
Support for diagnostic testing operations, quality systems, validation, documentation, suppliers, and FDA-related responsibilities.
Clinical Research Organizations
Support for study quality, documentation, vendor oversight, audit preparation, and BIMO inspection readiness.
Clinical Trial Sponsors
Support for sponsor oversight, clinical regulatory strategy, vendor management, documentation, and FDA inspection preparation.
Hospitals and Healthcare Systems
Support for medical device, diagnostic, laboratory, research, validation, implementation, and quality-related initiatives.
Research Institutions
Support for translating medical device and diagnostic technologies into regulated development and commercialization programs.
International Manufacturers Entering the United States
Support for FDA pathways, quality system expectations, submissions, United States Agent needs, and market entry planning.
Regulatory and Quality Support Built Around Your Organization
Tell us about your product, organization, or compliance challenge.
Discuss Your Needs